2025-06-23
Lindahl recognised as one of Sweden’s leading patent law firms by The Patent Lawyer Magazine 2025
Lindahl has been named one of Sweden’s top ten law firms in the field of patent law by The Patent Lawyer Magazine. The recognition highlights firms that stand out through quality, business relevance and active engagement in their field.
In its latest international edition, The Patent Lawyer Magazine has recognised Lindahl as one of the top ten Swedish law firms in the area of patent law. The selection is based on editorial research and assessment of firms’ work within intellectual property, with a particular focus on patent-related advice.
The ranking is based on several criteria, including recent matters and achievements, visibility within the industry, client testimonials, and participation in IP networks and knowledge-sharing initiatives. The aim is to showcase firms that demonstrate high-quality legal work, commercial value and deep involvement in their area of expertise.
“At a time when innovation is business-critical, our role as patent advisors is more important than ever. This recognition is a testament to the work we do together with our clients,” says Johan Norderyd, partner and head of Lindahl’s Intellectual Property group.
Lindahl’s IP team works daily to help clients protect, develop and commercialise their innovations. The firm provides strategic advice on all aspects of patent law – from protection and licensing to disputes and portfolio management.
The ranking by The Patent Lawyer Magazine affirms Lindahl’s strong position in the Swedish IP market and reflects the trust placed in the firm by both clients and industry peers.
Do you want to know more? Contact:
Johan Norderyd
Partner | AdvokatCarousel items
-
News articles
6/25/2026
Lindahl recognised in IP Stars 2026
Lindahl advances to Tier 2 in Copyright & related rights in IP Stars 2026, retains strong rankings in trade mark law, and sees several lawyers recognised with individual awards.
-
Cases and transactions
6/23/2026
Lindahl acts as legal adviser to Medivir in a private placement of approximately 140 MSEK
Lindahl acted as legal adviser to Medivir in connection with an oversubscribed private placement of SEK 140 million for the clinical development of the drug candidate MIV-711.
-
Knowledge
6/15/2026
Properly prepared — contract law in the new security landscape
Preparedness laws such as the Rationing Act and the Requisition Act can alter your contracts from one day to the next. Lindahl cuts through the terminology in the new security landscape.
-
Portraits
6/2/2026
Björn on M&A at Lindahl: "No two deals are alike"
Björn Andersson on M&A at Lindahl: how each transaction brings new challenges – and why no two deals are alike. Read about his experience and approach.
-
Read more news and insights?